DESCRIPTIONS OF MEDICAL FUNGI
fungus3-book
fungus3-book
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Descriptions of Medical Fungi 175<br />
Saksenaea vasiformis Complex<br />
The genus Saksenaea is characterised by the formation of flask-shaped sporangia with<br />
columellae and simple, darkly pigmented rhizoids. It is an emerging human pathogen<br />
(Holland, 1997) that is most often associated with cutaneous or subcutaneous lesions<br />
after trauma. Until recently, Saksenaea vasiformis was the only known species with a<br />
worldwide distribution in association with soil. However S. vasiformis has recently been<br />
split into three species; S. vasiformis, S erythrospora and S. oblongispora (Alvarez et<br />
al. 2010b). All three species have been isolated from clinical samples, but as yet no<br />
proven case reports have been published on the new species (de Hoog et al. 2015).<br />
Saksenaea vasiformis Saksena<br />
Morphological Description: Colonies are fast growing, downy, white with no reverse<br />
pigment, and made up of broad, non-septate hyphae typical of a mucormycetous<br />
fungus. Sporangia are typically flask-shaped with a distinct spherical venter and longneck,<br />
arising singly or in pairs from dichotomously branched, darkly pigmented rhizoids.<br />
Collumellae are prominent and dome-shaped. Sporangiospores are small, oblong, 1-2<br />
x 3-4 µm, and are discharged through the neck following the dissolution of an apical<br />
mucilaginous plug. RG-2 organism.<br />
Key Features: Mucorales, unique flask-shaped sporangia, failure to sporulate on<br />
primary isolation media.<br />
Molecular Identification: ITS sequencing is required for differentiation of species<br />
within the complex, and may be necessary to achieve identification in a timely manner<br />
(Alvarez et al. 2010b, Walther et al. 2012, Halliday et al. 2015).<br />
Comment: Laboratory identification of this fungus may be difficult or delayed because of<br />
the mould’s failure to sporulate on primary isolation media or on subsequent subculture<br />
onto potato dextrose agar. Sporulation may be stimulated by using the agar block<br />
method described by Ellis and Ajello (1982), Ellis and Kaminski (1985) and Padhye<br />
and Ajello (1988), although this may still take a period of days to weeks. Failure to<br />
sporulate prohibits antifungal susceptibility testing.<br />
The agar block method to induce sporulation<br />
of Saksenaea spp. and Apophysomyces<br />
spp.<br />
A small block of agar is cut from a well<br />
established culture grown on PDA and is<br />
placed in the centre of petri dish containing<br />
1% agar in distilled water. After 21 days<br />
at 26 O C sporangia might be formed at the<br />
periphery of the petri dish.<br />
Antifungal Susceptibility: S. vasiformis very limited data, due to poor sporulation<br />
(Sun et al. 2002 and Australian national data); MIC µg/mL.<br />
Antifungal Range MIC 90<br />
Antifungal Range MIC 90<br />
AmB 0.125-2 2 POSA 0.016-0.25 0.25<br />
ITRA 0.016-0.03 0.03 VORI 0.5-4 4